Clinical Trial Update: Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating carboplatin-based chemotherapy with or without panitumumab for platinum-sensitive recurrent ovarian cancer; status is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Panitumumab (Vectibix) (panitumumab)

Snippet

Sponsor: WiSP Wissenschaftlicher Service Pharma GmbH | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN